Ropes & Gray-Advised Neurogastrx Closes $60M Series B
Gastrointestinal disorder-focused pharmaceutical company Neurogastrx, advised by Ropes & Gray LLP, said Thursday that it has raised $60 million in a crossover funding round led by health care investment firm Vivo...To view the full article, register now.
Already a subscriber? Click here to view full article